Corcept Therapeutics Shares Outstanding 2006-2018 | CORT

Corcept Therapeutics shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Corcept Therapeutics shares outstanding for the quarter ending June 30, 2018 were 0.128B, a 3.66% increase year-over-year.
  • Corcept Therapeutics 2017 shares outstanding were 0.125B, a 7.21% increase from 2016.
  • Corcept Therapeutics 2016 shares outstanding were 0.116B, a 8.66% increase from 2015.
  • Corcept Therapeutics 2015 shares outstanding were 0.107B, a 5.85% increase from 2014.
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
2009 52
2008 47
2007 34
2006 23
2005 23
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 128
Q1 2018 128
Q4 2017 125
Q3 2017 126
Q2 2017 123
Q1 2017 121
Q4 2016 116
Q3 2016 116
Q2 2016 115
Q1 2016 110
Q4 2015 107
Q3 2015 108
Q2 2015 108
Q1 2015 102
Q4 2014 101
Q3 2014 101
Q2 2014 101
Q1 2014 101
Q4 2013 100
Q3 2013 100
Q2 2013 100
Q1 2013 100
Q4 2012 93
Q3 2012 99
Q2 2012 89
Q1 2012 84
Q4 2011 83
Q3 2011 84
Q2 2011 84
Q1 2011 81
Q4 2010 68
Q3 2010 72
Q2 2010 66
Q1 2010 63
Q4 2009 52
Q3 2009 50
Q2 2009 50
Q1 2009 50
Q4 2008 47
Q3 2008 49
Q2 2008 48
Q1 2008 40
Q4 2007 34
Q3 2007 37
Q2 2007 35
Q1 2007 26
Q4 2006 23
Q3 2006 23
Q2 2006 23
Q1 2006 23
Q4 2005 23
Q3 2005 23
Q2 2005 23
Q1 2005 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.412B $0.159B
Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.195B 11.27
Zoetis (ZTS) United States $44.072B 31.98
Tilray (TLRY) United States $13.534B 0.00
Grifols (GRFS) Spain $13.213B 16.13
Neurocrine Biosciences (NBIX) United States $10.133B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.423B 13.87
Nektar Therapeutics (NKTR) United States $8.311B 9.72
Ionis Pharmaceuticals (IONS) United States $6.203B 0.00
Catalent (CTLT) United States $6.007B 25.86
Sage Therapeutics (SAGE) United States $5.708B 0.00
Impax Laboratories (AMRX) United States $5.590B 0.00
United Therapeutics (UTHR) United States $5.356B 6.88
Loxo Oncology (LOXO) United States $4.875B 0.00
FibroGen (FGEN) United States $4.461B 0.00
Endo (ENDP) Ireland $3.926B 5.64
Taro Pharmaceutical Industries (TARO) Israel $3.745B 14.50
Madrigal Pharmaceuticals (MDGL) United States $2.958B 0.00
Aerie Pharmaceuticals (AERI) United States $2.640B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.559B 0.00
USANA Health Sciences (USNA) United States $2.532B 22.31
TESARO (TSRO) United States $2.293B 0.00
Heron Therapeutics (HRTX) United States $2.264B 0.00
Xencor (XNCR) United States $1.955B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.925B 0.00
PTC Therapeutics (PTCT) United States $1.910B 0.00
Endocyte (ECYT) United States $1.651B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.605B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.530B 18.71
Zogenix (ZGNX) United States $1.488B 0.00
Portola Pharmaceuticals (PTLA) United States $1.448B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.397B 0.00
TherapeuticsMD (TXMD) United States $1.269B 0.00
Tricida (TCDA) United States $1.265B 0.00
Esperion Therapeutics (ESPR) United States $1.206B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.149B 0.00
ImmunoGen (IMGN) United States $1.107B 0.00
Radius Health (RDUS) United States $0.862B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.785B 0.00
Karyopharm Therapeutics (KPTI) United States $0.743B 0.00
Flexion Therapeutics (FLXN) United States $0.716B 0.00
GlycoMimetics (GLYC) United States $0.609B 0.00
Dova Pharmaceuticals (DOVA) United States $0.582B 0.00
ChemoCentryx (CCXI) United States $0.574B 33.56
Dermira (DERM) United States $0.550B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.549B 0.00
Collegium Pharmaceutical (COLL) United States $0.545B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.496B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.474B 0.00
ArQule (ARQL) United States $0.470B 0.00
OptiNose (OPTN) United States $0.470B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.456B 31.09
Forty Seven (FTSV) United States $0.451B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.424B 0.00
Xeris Pharmaceuticals (XERS) United States $0.415B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.415B 0.00
Odonate Therapeutics (ODT) United States $0.411B 0.00
Minerva Neurosciences (NERV) United States $0.410B 0.00
Siga Technologies (SIGA) United States $0.401B 0.00
Aclaris Therapeutics (ACRS) United States $0.387B 0.00
Zafgen (ZFGN) United States $0.382B 0.00
Depomed (ASRT) United States $0.368B 0.00
Aquestive Therapeutics (AQST) United States $0.358B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.354B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.352B 0.00
Concert Pharmaceuticals (CNCE) United States $0.347B 0.00
ElectroCore (ECOR) United States $0.341B 0.00
KalVista Pharmaceuticals (KALV) United States $0.340B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.340B 0.00
Mast Therapeutics (SVRA) United States $0.333B 0.00
Majesco Entertainment (PTE) United States $0.275B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.270B 0.00
MEI Pharma (MEIP) United States $0.267B 0.00
CASI Pharmaceuticals (CASI) United States $0.265B 0.00
Translate Bio (TBIO) United States $0.263B 0.00
Aratana Therapeutics (PETX) United States $0.256B 0.00
IMV INC (IMV) Canada $0.252B 0.00
Neon Therapeutics (NTGN) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Opexa Therapeutics (ACER) United States $0.246B 0.00
Ardelyx (ARDX) United States $0.241B 0.00
Tyme Technologies (TYME) United States $0.241B 0.00
Ocular Therapeutix (OCUL) United States $0.238B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.232B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.225B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.220B 0.00
Melinta Therapeutics (MLNT) United States $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.202B 0.00
Affimed (AFMD) Germany $0.200B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.182B 0.00
Achaogen (AKAO) United States $0.181B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Molecular Templates (MTEM) United States $0.171B 0.00
DURECT (DRRX) United States $0.168B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Nature's Sunshine Products (NATR) United States $0.159B 0.00
ContraFect (CFRX) United States $0.152B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.151B 0.00
Lannett Co Inc (LCI) United States $0.151B 1.25
Recro Pharma (REPH) United States $0.150B 0.00
Infinity Pharmaceuticals (INFI) United States $0.145B 0.00
Adherex Technologies (FENC) United States $0.143B 0.00
Champions Oncology (CSBR) United States $0.143B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.139B 0.00
ProNAi Therapeutics (SRRA) Canada $0.132B 0.00
Neos Therapeutics (NEOS) United States $0.123B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.123B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
CTI BioPharma (CTIC) United States $0.112B 0.00
BioLineRx (BLRX) Israel $0.104B 0.00
Forward Pharma (FWP) Denmark $0.100B 0.00
ENTASIS THERAPT (ETTX) United States $0.097B 0.00
Iterum Therapeutics (ITRM) Ireland $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 0.00
Immune Design (IMDZ) United States $0.080B 0.00
Otonomy (OTIC) United States $0.080B 0.00
Natural Alternatives (NAII) United States $0.071B 7.95
Nivalis Therapeutics (ALPN) United States $0.069B 0.00
Novan (NOVN) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Trillium Therapeutics (TRIL) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.30
KemPharm (KMPH) United States $0.040B 0.00
Capnia (SLNO) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.039B 0.00
Avenue Therapeutics (ATXI) United States $0.038B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 9.40
Lipocine (LPCN) United States $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.025B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.018B 1.81
Aradigm (ARDM) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Midatech Pharma (MTP) United Kingdom $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00